Michael J. Morris
机构：Memorial Sloan Kettering Cancer Center · ORCID：0000-0002-9454-0096
发表论文 887 篇 · 总被引 42698 次 · h-index 91
代表论文
- Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801) (2026 · Journal of Clinical Oncology · 被引 1)
- 68Ga-PSMA PET/CT in biochemically recurrent prostate cancer: association with genomic data (2026 · European Journal of Nuclear Medicine and Molecular Imaging)
- Reply to: PCWG4: A Missed Opportunity to Make Bone-Protective Agents Mandatory for Patients With Bone Metastatic Castration-Resistant Prostate Cancer (2026 · Journal of Clinical Oncology)
- Supplementary Data and Methods 1 from Automated Imaging as an Adjunct to Serum and Clinical Biomarkers: A New Validated Prediction Tool for Metastatic Castration-Resistant Prostate Cancer (2026)
- Data from Automated Imaging as an Adjunct to Serum and Clinical Biomarkers: A New Validated Prediction Tool for Metastatic Castration-Resistant Prostate Cancer (2026)
- Supplementary Data 1 from Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA-Targeted Tubulysin Conjugate EC1169 (2026)